Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy

MLA

Si Dong, et al. “Nucleobase-Crosslinked Poly(2-Oxazoline) Nanoparticles as Paclitaxel Carriers with Enhanced Stability and Ultra-High Drug Loading Capacity for Breast Cancer Therapy.” Asian Journal of Pharmaceutical Sciences, vol. 17, no. 4, July 2022, pp. 571–82. EBSCOhost, https://doi.org/10.1016/j.ajps.2022.04.006.

APA

Si Dong, Sheng Ma, Hongyu Chen, Zhaohui Tang, Wantong Song, & Mingxiao Deng. (2022). Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy. Asian Journal of Pharmaceutical Sciences, 17(4), 571–582. https://doi.org/10.1016/j.ajps.2022.04.006

Chicago

Si Dong, Sheng Ma, Hongyu Chen, Zhaohui Tang, Wantong Song, and Mingxiao Deng. 2022. “Nucleobase-Crosslinked Poly(2-Oxazoline) Nanoparticles as Paclitaxel Carriers with Enhanced Stability and Ultra-High Drug Loading Capacity for Breast Cancer Therapy.” Asian Journal of Pharmaceutical Sciences 17 (4): 571–82. doi:10.1016/j.ajps.2022.04.006.